Srinidi Mohan

Education

B.Sc University of Madras, 2000

M.Sc University of Madras, 2003

Ph.D. Mississippi State University, 2006

Research Interests

Drug Delivery and Formulation, Genomics, Molecular Biology, Proteomics, Cancer Biomarkers

Selected Publications

Dr. Mohan lab., Press Coverage

  • 2018 : https://www.une.edu/news/2018/srinidi-mahon%E2%80%99s-breast-cancer-detection-and-monitoring-patent-featured-wcsh-and-portland-press
  • 2017 : https://www.une.edu/news/2017/%E2%80%98associated-press%E2%80%99-highlights-une%E2%80%99s-srinidi-mohan-breast-cancer-research-funding
  • 2016 : https://www.une.edu/news/2016/pharmacy-professor-srinidi-mohan-receives-two-grants-breast-cancer-detection-marker:

Patent(s)

  • Mohan, S. (2018). Methods and Diagnostics for Cancer Detection and Treatment Monitoring [U.S. Patent number., 10,073,099].
  • Mohan. S. (2021). Methods and diagnostics for cancer detection and treatment monitoring. [U.S. patent number 11,009,507].

Selective Peer-Reviewed Publications (from 2011 – present)

*, indicates corresponding author

  • Mohan, S*., Patel, S., Barlow, D., Rojas, A.C. (2020). Predictive response of a simple and sensitive blood-based biomarker between estrogen-negative solid tumors. Advances in Medical Sciences. 65:424-428. doi: 10.1016/j.advms.2020.08.004
  • Mohan, S*., Lawton, S., Palmer, C., Rojas, A.C. (2019). Competitive ELISA method for novel estrogen-negative breast cancer biomarker quantification. Journal of Immunological Methods. 474:112671. doi: 10.1016/j.jim.2019.112671
  • Mohan, S*., Patel, S., Greenstein, I., Ng, C., Frazier, K., Nguyen, G., Harding, L., Barlow, D. (2018). Metabolic relevance for N-hydroxy L-arginine reduction in estrogen-negative breast cancer cells. Amino Acids. doi:10.1007/s00726-018-2603-x.
  • Mohan, S*., Greenstein, I., Ng, C., Frazier, K., Nguyen, G., Harding, L. (2017). Assessing Nw-hydroxy-L-arginine applicability as a novel ethnic specific estrogen-negative breast cancer marker. Amino Acids Journal. 50 (3–4: 373-382. doi: 10.1007/s00726-017-2523-1.
  • Mohan, S*., Harding, L., Moua, N. (2016). Nw-hydroxy-L-arginine as a novel ethnic specific indicator of estrogen-negative breast cancer. Amino Acids. 48(11):2693-2698. DOI :10.1007/s00726-016-2301-5.
  • Mohan, S*., Harding, L. (2016). Maintenance of Cytosolic Calcium is Crucial to Extend L-Arginine Therapeutic Benefits During Continuous Dosing. Nutrition Research.36(10):1114-1120. DOI: 10.1016/j.nutres.2016.07.002
  • Mohan, S*., Benson, C. (2014). Understanding the metabolic possibilities for L-Arginine tolerance development. Austin Journal of Nutrition and Food Sciences. 2(2):6.
  • Mohan S*, Patel H, Bolinaga J, Soekamto N. (2013). AMP-activated protein kinase regulates L-arginine mediated cellular responses. Nutrition and Metabolism. 10:40
  •  Mohan S*, Patel H, Bolinaga J, Soekamto N, Achu L, Teklemariam K. (2012). Dihydrobiopterin (BH2): Key Determinant in influencing arginine mediated endothelial tolerance and dysfunction. American Journal of Biochemistry and Biotechnology. 8:54-62
  • Mohan S, Fung HL. (2012). Mechanism of cellular oxidation stress induced by asymmetric dimethylarginine. International Journal of Molecular Sciences. 13:7521-7531
  • Mohan S, Wu CC, Shin S, Fung HL. (2011). Continuous exposure to L-arginine induces oxidative stress and physiological tolerance in cultured human endothelial cells. Amino Acids. 43:1179-88
  • Shin S, Mohan S, Fung HL. (2011). Intracellular L-arginine concentration does not determine NO production in endothelial cells: Implications on the “L-arginine paradox”. Biochemical and Biophysical Research Communications. 414:660-663
  • Shin S, Fung S-M, Mohan S, Fung HL. (2011). Simultaneous bio-analysis of L-Arginine, L-Citrulline and dimethylarginases by LC-MS/MS. Journal of Chromatography B. 876:467- 474